» Articles » PMID: 28496545

C-Reactive Protein and Frailty in the Elderly: A Literature Review

Overview
Journal J Clin Med Res
Specialty General Medicine
Date 2017 May 13
PMID 28496545
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation is a well-established background process in many age-related diseases. Many recent studies investigate the use of various inflammatory biomarkers such as C-reactive protein (CRP), interleukin-6, and interleukin-1 as predictors of physical and cognitive performance among elders. The phenotype of frailty has also been associated with underlying inflammatory mechanisms. The aim of this article was to review the literature referring to the correlation of CRP serum levels and frailty in older individuals. We tried to identify all relevant publications regarding the relation of CRP as an index of frailty in the elderly and its potential use. Although many studies in the recent medical literature positively associate serum CRP levels and frailty in older individuals, some do not, and some raise some interesting questions and set the basis for future studies. The association of CRP and frailty in elder patients should be considered when clinicians interpret inflammatory biomarkers in various clinical settings in such patients. Well-designed, prospective clinical trials are warranted to better assess the role and pathophysiology of frailty in the elderly and its mechanisms as also the exact role of CRP as an inflammatory marker and as a prognostic index in this syndrome.

Citing Articles

Risk Factors for Postoperative Acute Kidney Injury Requiring Renal Replacement Therapy in Patients Undergoing Heart Valve Surgery.

Duchnowski P, Smigielski W J Clin Med. 2025; 13(24.

PMID: 39768734 PMC: 11677406. DOI: 10.3390/jcm13247811.


Frailty transitions and associated factors in older cancer survivors in the USA: using a multi-state modeling.

Zhou W, Cho Y, Shang S, Li Y, Seo J, Pu J J Cancer Surviv. 2024; .

PMID: 39690394 DOI: 10.1007/s11764-024-01734-9.


The association of multidimensional frailty with metabolic syndrome and low-grade inflammation in community-dwelling older adults in the Netherlands: a Lifelines cohort study.

Sealy M, van Vliet I, Jager-Wittenaar H, Navis G, Zhu Y Immun Ageing. 2024; 21(1):78.

PMID: 39538284 PMC: 11558828. DOI: 10.1186/s12979-024-00484-7.


The Effect of Exercise Program Interventions on Frailty, Clinical Outcomes, and Biomarkers in Older Adults: A Systematic Review.

Prommaban A, Moonkayaow S, Phinyo P, Siviroj P, Sirikul W, Lerttrakarnnon P J Clin Med. 2024; 13(21).

PMID: 39518709 PMC: 11547147. DOI: 10.3390/jcm13216570.


Considerations on Multimorbidity and Frailty in Inflammatory Bowel Diseases.

Carbery I, Selinger C, Todd O, Sebastian S J Crohns Colitis. 2024; 18(Supplement_2):ii46-ii54.

PMID: 39475079 PMC: 11523040. DOI: 10.1093/ecco-jcc/jjae067.


References
1.
Morley J, Baumgartner R . Cytokine-related aging process. J Gerontol A Biol Sci Med Sci. 2004; 59(9):M924-9. DOI: 10.1093/gerona/59.9.m924. View

2.
Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R . Inflammation and frailty in the elderly: A systematic review and meta-analysis. Ageing Res Rev. 2016; 31:1-8. DOI: 10.1016/j.arr.2016.08.006. View

3.
Wallet M, Buford T, Joseph A, Sankuratri M, Leeuwenburgh C, Pahor M . Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects. BMC Immunol. 2015; 16:43. PMC: 4513956. DOI: 10.1186/s12865-015-0106-z. View

4.
Bourdel-Marchasson I, Laksir H, Puget E . Interpreting routine biochemistry in those aged over 65 years: a time for change. Maturitas. 2010; 66(1):39-45. DOI: 10.1016/j.maturitas.2010.02.004. View

5.
Nouvenne A, Ticinesi A, Lauretani F, Maggio M, Lippi G, Prati B . The Prognostic Value of High-sensitivity C-reactive Protein and Prealbumin for Short-term Mortality in Acutely Hospitalized Multimorbid Elderly Patients: A Prospective Cohort Study. J Nutr Health Aging. 2016; 20(4):462-8. DOI: 10.1007/s12603-015-0626-5. View